Assignee
GENAERA CORP
US·21 granted patents·4 pending applications·258 citations·filing 1999–2008
Top patents by PatentIndex Score
25 records- 0194US7700088B2Interleukin-9 mutein peptidesGENAERA CORP·Filed 2007·Granted Apr 20, 2010·17 cites·16 claims
- 0289US6962909B2Treatment of neovascularization disorders with squalimineGENAERA CORP·Filed 2001·Granted Nov 8, 2005·26 cites·16 claims
- 0389US6596712B2Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalitiesGENAERA CORP·Filed 2001·Granted Jul 22, 2003·36 cites·14 claims
- 0488US7192578B2Interleukin-9 mutein peptidesGENAERA CORP·Filed 2003·Granted Mar 20, 2007·17 cites·12 claims
- 0587US6261559B1Methods of treating asthma with interleukin-9 antibodiesGENAERA CORP·Filed 1999·Granted Jul 17, 2001·42 cites·17 claims
- 0686US7345051B2Mucin synthesis inhibitorsGENAERA CORP·Filed 2002·Granted Mar 18, 2008·30 cites·27 claims
- 0784US6737427B2Mucin synthesis inhibitorsGENAERA CORP·Filed 2001·Granted May 18, 2004·19 cites·59 claims
- 0881US6645492B2Methods of treating asthma with interleukin-9 receptor antibodiesGENAERA CORP·Filed 2001·Granted Nov 11, 2003·8 cites·17 claims
- 0977US7504409B2Mucin synthesis inhibitorsGENAERA CORP·Filed 2004·Granted Mar 17, 2009·9 cites·58 claims
- 1074US7410959B1Therapeutic uses for aminosterol compoundsGENAERA CORP·Filed 2000·Granted Aug 12, 2008·6 cites·17 claims
- 1173US7056698B2Nucleic acids encoding interleukin-9 receptor variantsGENAERA CORP·Filed 2002·Granted Jun 6, 2006·1 cites·13 claims
- 1273US6602850B1Method of treating asthma using soluble IL-9 receptor variantsGENAERA CORP·Filed 2000·Granted Aug 5, 2003·1 cites·27 claims
- 1372US7074778B2Asthma associated factors as targets for treating atopic allergies including asthma and related disordersGENAERA CORP·Filed 2000·Granted Jul 11, 2006·5 cites·7 claims
- 1469US6716603B2Nucleic acids encoding a chloride channel proteinGENAERA CORP·Filed 2002·Granted Apr 6, 2004·3 cites·18 claims
- 1567US7704710B2Interleukin-9 receptor mutantsGENAERA CORP·Filed 2008·Granted Apr 27, 2010·0 cites·18 claims
- 1667US7208292B2Nucleic acid encoding an interleukin-9 receptor variantGENAERA CORP·Filed 2006·Granted Apr 24, 2007·0 cites·10 claims
- 1767US6388108B1Aminosterol compounds and uses thereofGENAERA CORP·Filed 1999·Granted May 14, 2002·25 cites·24 claims
- 1865US6933383B2Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterolsGENAERA CORP·Filed 2002·Granted Aug 23, 2005·3 cites·4 claims
- 1963US7384767B2Nucleic acid encoding an interleukin-9 receptor variantGENAERA CORP·Filed 2007·Granted Jun 10, 2008·0 cites·18 claims
- 2059US2006166950A1Treatment of neovascularization disorders with squalamineGENAERA CORP·Filed 2006·Application pending·0 cites
- 2156US7211254B2Methods for treating ICACC protein associated diseasesGENAERA CORP·Filed 2004·Granted May 1, 2007·0 cites·12 claims
- 2256US6576434B1Methods for identification of agents which modulate chloride channel activityGENAERA CORP·Filed 1999·Granted Jun 10, 2003·10 cites·32 claims
- 2355US2006183928A1Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compoundsGENAERA CORP·Filed 2004·Application pending·0 cites
- 2452US2007088003A1Asthma associated factors as targets for treating atopic allergies including asthma and related disordersGENAERA CORP·Filed 2006·Application pending·0 cites
- 2545US2008096981A1Antibodies against inducible TH2 cell factorsGENAERA CORP·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENAERA CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →